Evidence map›Paper›PMID 41804477›Full record

ArticlePulmonary circulation2026

Industry Payments and Prescribing Patterns of Pulmonary Hypertension Therapies in the United States.

Elizabeth S Tarras, Anju Murayama, Inderjit Singh, Lina M Freeman, Hinari Kugo, Deborah C Marshall

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Pulmonary circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Elizabeth S TarrasDepartment of Pulmonary, Critical Care, and Sleep Medicine Yale School of Medicine New Haven Connecticut USA.
Anju MurayamaDepartment of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York New York USA.
Inderjit SinghDepartment of Pulmonary, Critical Care, and Sleep Medicine Yale School of Medicine New Haven Connecticut USA.ORCID https://orcid.org/0000-0001-5624-1274
Lina M FreemanClinical Training Center Ashikaga Red Cross Hospital Ashikaga Tochigi Japan.
Hinari KugoSchool of Medicine Tohoku University Sendai Miyagi Japan.
Deborah C MarshallDepartment of Population Health Science and Policy Icahn School of Medicine at Mount Sinai New York New York USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study analyzed the US Open Payments and Medicare Part D databases from 2014 to 2022 to assess associations between industry-physician payments and PAH therapy prescribing. Among 5502 pulmonologist-, cardiologist- and pediatrician-prescribers of PAH therapies, drug-specific industry payments were associated with dose-response increases in Medicare spending.

Indexed as

conflict of interestmedicarepulmonary arterial hypertension

Identifiers

PMID41804477
PMCPMC12967594

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.